Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Regional Variations and Intra-/Intersession Repeatability for Scotopic Sensitivity in Normal Controls and Patients With Inherited Retinal Degenerations.

Bennett LD, Metz G, Klein M, Locke KG, Khwaja A, Birch DG.

Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1122-1131. doi: 10.1167/iovs.18-25473.

2.

Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa.

Bennett LD, Klein M, Locke KG, Kiser K, Birch DG.

Transl Vis Sci Technol. 2017 Aug 9;6(4):15. doi: 10.1167/tvst.6.4.15. eCollection 2017 Jul.

3.

North Carolina macular dystrophy (MCDR1) caused by a novel tandem duplication of the PRDM13 gene.

Bowne SJ, Sullivan LS, Wheaton DK, Locke KG, Jones KD, Koboldt DC, Fulton RS, Wilson RK, Blanton SH, Birch DG, Daiger SP.

Mol Vis. 2016 Oct 17;22:1239-1247. eCollection 2016.

4.

Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes.

Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT.

BMC Ophthalmol. 2016 Jul 29;16(1):129. No abstract available.

5.

Reliability of a Manual Procedure for Marking the EZ Endpoint Location in Patients with Retinitis Pigmentosa.

Ramachandran R, X Cai C, Lee D, C Epstein B, Locke KG, G Birch D, C Hood D.

Transl Vis Sci Technol. 2016 May 17;5(3):6. eCollection 2016 May.

6.

Worldwide Argus II implantation: recommendations to optimize patient outcomes.

Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT.

BMC Ophthalmol. 2016 May 6;16:52. doi: 10.1186/s12886-016-0225-1. Review. Erratum in: BMC Ophthalmol. 2016;16(1):129.

7.

Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.

Hoffman DR, Hughbanks-Wheaton DK, Spencer R, Fish GE, Pearson NS, Wang YZ, Klein M, Takacs A, Locke KG, Birch DG.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6646-53. doi: 10.1167/iovs.15-17786.

8.

Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa.

Birch DG, Locke KG, Felius J, Klein M, Wheaton DK, Hoffman DR, Hood DC.

Ophthalmology. 2015 Apr;122(4):833-9. doi: 10.1016/j.ophtha.2014.11.005. Epub 2014 Dec 31.

9.

A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and x-linked retinitis pigmentosa.

Cai CX, Locke KG, Ramachandran R, Birch DG, Hood DC.

Invest Ophthalmol Vis Sci. 2014 Oct 23;55(11):7417-22. doi: 10.1167/iovs.14-15013.

10.

Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.

Hoffman DR, Hughbanks-Wheaton DK, Pearson NS, Fish GE, Spencer R, Takacs A, Klein M, Locke KG, Birch DG.

JAMA Ophthalmol. 2014 Jul;132(7):866-73. doi: 10.1001/jamaophthalmol.2014.1634.

11.

A Comparison of Methods for Tracking Progression in X-Linked Retinitis Pigmentosa Using Frequency Domain OCT.

Ramachandran R, Zhou L, Locke KG, Birch DG, Hood DC.

Transl Vis Sci Technol. 2013 Nov;2(7):5. Epub 2013 Nov 11.

12.

Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.

Birch DG, Locke KG, Wen Y, Locke KI, Hoffman DR, Hood DC.

JAMA Ophthalmol. 2013 Sep;131(9):1143-50. doi: 10.1001/jamaophthalmol.2013.4160.

13.

Rod photoreceptor temporal properties in retinal degenerative diseases.

Wen Y, Locke KG, Hood DC, Birch DG.

Adv Exp Med Biol. 2012;723:495-502. doi: 10.1007/978-1-4614-0631-0_62. No abstract available.

14.

Phenotypic characterization of 3 families with autosomal dominant retinitis pigmentosa due to mutations in KLHL7.

Wen Y, Locke KG, Klein M, Bowne SJ, Sullivan LS, Ray JW, Daiger SP, Birch DG, Hughbanks-Wheaton DK.

Arch Ophthalmol. 2011 Nov;129(11):1475-82. doi: 10.1001/archophthalmol.2011.307.

15.

ApoER2 function in the establishment and maintenance of retinal synaptic connectivity.

Trotter JH, Klein M, Jinwal UK, Abisambra JF, Dickey CA, Tharkur J, Masiulis I, Ding J, Locke KG, Rickman CB, Birch DG, Weeber EJ, Herz J.

J Neurosci. 2011 Oct 5;31(40):14413-23. doi: 10.1523/JNEUROSCI.3135-11.2011.

16.

Rod photoreceptor temporal properties in retinitis pigmentosa.

Wen Y, Locke KG, Hood DC, Birch DG.

Exp Eye Res. 2011 Mar;92(3):202-8. doi: 10.1016/j.exer.2010.12.014. Epub 2011 Jan 8.

17.

The transition zone between healthy and diseased retina in patients with retinitis pigmentosa.

Hood DC, Lazow MA, Locke KG, Greenstein VC, Birch DG.

Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):101-8. doi: 10.1167/iovs.10-5799.

18.

A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa.

Rangaswamy NV, Patel HM, Locke KG, Hood DC, Birch DG.

Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4213-9. doi: 10.1167/iovs.09-4945. Epub 2010 Mar 10.

19.

Macular atrophy in birdshot retinochoroidopathy: an optical coherence tomography and multifocal electroretinography analysis.

Birch DG, Williams PD, Callanan D, Wang R, Locke KG, Hood DC.

Retina. 2010 Jun;30(6):930-7. doi: 10.1097/IAE.0b013e3181c720b4.

20.

Photographic assessment of changes in torsional strabismus.

Felius J, Locke KG, Hussein MA, Stager DR Jr, Stager DR Sr.

J AAPOS. 2009 Dec;13(6):593-5. doi: 10.1016/j.jaapos.2009.09.008.

PMID:
20006824
21.

Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography.

Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG.

Invest Ophthalmol Vis Sci. 2009 May;50(5):2328-36. doi: 10.1167/iovs.08-2936. Epub 2008 Nov 14.

22.

Persistent cone dysfunction in acute exudative polymorphous vitelliform maculopathy.

Kozma P, Locke KG, Wang YZ, Birch DG, Edwards AO.

Retina. 2007 Jan;27(1):109-13. No abstract available.

PMID:
17218925
23.

The very large G-protein-coupled receptor VLGR1: a component of the ankle link complex required for the normal development of auditory hair bundles.

McGee J, Goodyear RJ, McMillan DR, Stauffer EA, Holt JR, Locke KG, Birch DG, Legan PK, White PC, Walsh EJ, Richardson GP.

J Neurosci. 2006 Jun 14;26(24):6543-53.

24.

Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene.

Kozma P, Hughbanks-Wheaton DK, Locke KG, Fish GE, Gire AI, Spellicy CJ, Sullivan LS, Bowne SJ, Daiger SP, Birch DG.

Am J Ophthalmol. 2005 Nov;140(5):858-867. Epub 2005 Oct 7.

25.

Functional characterization of mouse RDH11 as a retinol dehydrogenase involved in dark adaptation in vivo.

Kasus-Jacobi A, Ou J, Birch DG, Locke KG, Shelton JM, Richardson JA, Murphy AJ, Valenzuela DM, Yancopoulos GD, Edwards AO.

J Biol Chem. 2005 May 27;280(21):20413-20. Epub 2005 Mar 24.

26.

Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.

Karan G, Lillo C, Yang Z, Cameron DJ, Locke KG, Zhao Y, Thirumalaichary S, Li C, Birch DG, Vollmer-Snarr HR, Williams DS, Zhang K.

Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4164-9. Epub 2005 Mar 4.

27.

A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.

Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG.

Am J Ophthalmol. 2004 Apr;137(4):704-18.

PMID:
15059710
28.

Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.

Wheaton DH, Hoffman DR, Locke KG, Watkins RB, Birch DG.

Arch Ophthalmol. 2003 Sep;121(9):1269-78.

PMID:
12963609
29.

Cone and rod ERG phototransduction parameters in retinitis pigmentosa.

Tzekov RT, Locke KG, Hood DC, Birch DG.

Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3993-4000.

PMID:
12939320
30.

Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease.

Grover S, Fishman GA, Birch DG, Locke KG, Rosner B.

Ophthalmology. 2003 Jun;110(6):1159-63.

PMID:
12799241
31.

Cone deactivation kinetics and GRK1/GRK7 expression in enhanced S cone syndrome caused by mutations in NR2E3.

Cideciyan AV, Jacobson SG, Gupta N, Osawa S, Locke KG, Weiss ER, Wright AF, Birch DG, Milam AH.

Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1268-74.

PMID:
12601058
32.
33.

Shape discrimination in age-related macular degeneration.

Wang YZ, Wilson E, Locke KG, Edwards AO.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):2055-62.

PMID:
12037018
34.

Comparison of the Goldmann-Weekers dark adaptometer and LKC Technologies Scotopic Sensitivity tester-1.

Peters AY, Locke KG, Birch DG.

Doc Ophthalmol. 2000 Jul;101(1):1-9.

PMID:
11128963

Supplemental Content

Loading ...
Support Center